The Hanson Lab, a member of the Cornell Center for Enervating Neuroimmune Disease, published a metabolomics study in the journal Metabolites. The study examined prospective biomarkers in plasma from people with ME/CFS and identified findings that implicate redox imbalance in disease symptomatology. More information can be found on the Center’s Facebook page included below.

Read the full publication in Metabolites: “Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology” .